{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT00850564","recordId":"NCT00850564","peptideSlug":"tesamorelin","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00850564-tesamorelin/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct00850564.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct00850564.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2009-02-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2009-02-23","publishedAt":"2026-08-23","recordId":"NCT00850564","recordSha256":"ff2fd4a0daec5c10c576b45e212ef52b652e545205d02e5aac5a5a4dc2e36e12","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00850564?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2009-08-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2009-08-06","publishedAt":"2026-08-23","recordId":"NCT00850564","recordSha256":"9b4152ec5c02ad2fe899695b034015c54659490a1253bafdeb35f1b89d52116b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00850564?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Sponsor/Collaborators","Study Identification","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2010-04-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"tesamorelin","submittedDate":"2010-04-01","publishedAt":"2026-08-23","recordId":"NCT00850564","recordSha256":"e4c8cdf6d2c03afda6e93748fba9e19be40e31c991fbf0bee22646c7b03f741d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00850564?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2010-10-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"tesamorelin","submittedDate":"2010-10-04","publishedAt":"2026-08-23","recordId":"NCT00850564","recordSha256":"3e693ede9402e834028091f08dad1ac4700dceba7bc46b1a94494e754620da3a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00850564?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Baseline Characteristics","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","References","Study Design","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2011-03-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"tesamorelin","submittedDate":"2011-03-03","publishedAt":"2026-08-23","recordId":"NCT00850564","recordSha256":"3f85d1698a905e338f070f9e3a3cb2f7c6e168b141eb8e12532a8d618d02b36a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00850564?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Arms and Interventions","Baseline Characteristics","Outcome Measures","Outcome Measures (Results)","Participant Flow","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2011-04-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"tesamorelin","submittedDate":"2011-04-15","publishedAt":"2026-08-23","recordId":"NCT00850564","recordSha256":"b4a2752190d036de168c9e73c9add2850436ae63165707484e994ebe8a742dbb","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00850564?a=6&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"d9073941b6a5e4a1846616528ff88845ad22e538b703f7edacd56b2dc4a5870c"}}